Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 88, Issue 6, Pages 713-714

出版商

Ovid Technologies (Wolters Kluwer Health)

发表日期

2020-03-20

DOI

10.1097/ta.0000000000002694

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started